Page last updated: 2024-08-24

sipatrigine and Affective Psychosis, Bipolar

sipatrigine has been researched along with Affective Psychosis, Bipolar in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Tsai, SJ	1

Other Studies

1 other study(ies) available for sipatrigine and Affective Psychosis, Bipolar

Article	Year
Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1. Medical hypotheses, 2008, Volume: 70, Issue:3 Topics: Animals; Bipolar Disorder; Brain; Depressive Disorder; Humans; Mice; Models, Animal; Neuroprotective Agents; Piperazines; Potassium Channel Blockers; Potassium Channels, Tandem Pore Domain; Pyrimidines	2008

Article

Year

Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1.

Medical hypotheses, 2008, Volume: 70, Issue:3

Topics: Animals; Bipolar Disorder; Brain; Depressive Disorder; Humans; Mice; Models, Animal; Neuroprotective Agents; Piperazines; Potassium Channel Blockers; Potassium Channels, Tandem Pore Domain; Pyrimidines

2008